N-Trans-Feruloyldopamine
CAS 142350-99-0
N-Trans-Feruloyldopamine (CAS 142350-99-0) is a pharmaceutical compound with 3 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 32280 nM | 4 | - |
| - | IC50 | 20 ug.mL-1 | 3 | - |
| - | MIC | 93.75 ug.mL-1 | 2 | - |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is N-Trans-Feruloyldopamine used for in pharmaceutical contexts?
N-Trans-Feruloyldopamine (CAS 142350-99-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for N-Trans-Feruloyldopamine?
No adverse-event association or SIDER side-effect rows are rendered for N-Trans-Feruloyldopamine in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is N-Trans-Feruloyldopamine also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for N-FERULOYL DOPAMINE with EU status "restricted".
What clinical phase is N-Trans-Feruloyldopamine in?
No phase 1-4 clinical development badge is rendered for N-Trans-Feruloyldopamine because the matched compound identifier rows do not contain a max-phase value.